Black Diamond Therapeutics (BDTX) EV to FCF (2020 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly EV to FCF came in at 0.51 in Q2 2026, up 168.01% on a YoY basis from 0.19 in Q2 2025, and up 238.1% quarter-over-quarter from 0.37 in Q1 2026.
Analysis
Black Diamond Therapeutics (BDTX) EV to FCF (2020 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has reported EV to FCF for 7 consecutive years, with 0.51 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to FCF rose 168.01% year-over-year to 0.51; the trailing twelve-month figure through Jun 2026 stood at 0.13 (up 232.41% YoY), and the FY2025 full-year result was 0.34, up 194.52% from the prior year.
- EV to FCF advanced to 0.51 in Q2 2026 per BDTX's latest filing, from 0.37 in the prior quarter.
- Across five years, EV to FCF topped out at 5.02 in Q3 2022 and bottomed at 11.81 in Q3 2024.
- Historically, EV to FCF has averaged 1.9 across 5 years, with a median of 0.68 in 2023.
- The sharpest annual moves came in 2022 and 2024: EV to FCF surged 294.36% in 2022, then slumped 5417.38% in 2024.
- Over 5 years, EV to FCF stood at 2.61 in 2022, then slumped by 137.7% to 0.98 in 2023, then slumped by 53.4% to 1.51 in 2024, then slipped by 0.21% to 1.51 in 2025, then surged by 134.03% to 0.51 in 2026.
- According to Business Quant data, EV to FCF over the past three periods registered 0.51, 0.37, and 1.51 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Black Diamond Therapeutics | 111.58 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.51 |
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -1.51 |
| Sep 30, 2025 | -10.29 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | -1.21 |
| Dec 31, 2024 | -1.51 |
| Sep 30, 2024 | -11.81 |
| Jun 30, 2024 | -9.29 |
| Mar 31, 2024 | -7.13 |
| Dec 31, 2023 | -0.98 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -6.61 |
| Mar 31, 2023 | 1.72 |
| Dec 31, 2022 | 2.61 |
| Sep 30, 2022 | 5.02 |
| Jun 30, 2022 | 3.92 |
| Mar 31, 2022 | 2.77 |
| Dec 31, 2021 | 0.68 |
| Sep 30, 2021 | -2.58 |